Concepedia
Statistics
Publications
29
Citations
1.1K
H-Index
20
Active since
2000
Affiliations
Technion – Israel Institute of Technology(Current)
Rappaport Family Institute for Research in the Medical Sciences
Tel Aviv University
Geha Mental Health Center
Tel Aviv Sourasky Medical Center
Leo Veenman is an author at Technion – Israel Institute of Technology specializing in pharmacology, medicine, and oncology.
Publications per year
2000–2019
Peripheral-type benzodiazepine receptor density and in vitro tumorigenicity of glioma cell lines
Leo Veenman, Evgeny Levin, Gary Weisinger et al. · Biochemical Pharmacology · 2004 · 94 citations
Medicine, Oncology, Pharmacology +9
CoCl<sub>2</sub>Induces Apoptosis via the 18 kDa Translocator Protein in U118MG Human Glioblastoma Cells
Sivan Zeno, Menashe Zaaroor, Svetlana Leschiner et al. · Biochemistry · 2009 · 83 citations
Life Sciences, Oncology, Pharmacology +17
The Peripheral-Type Benzodiazepine Receptor and Tumorigenicity: Isoquinoline Binding Protein (IBP) Antisense Knockdown in the C6 Glioma Cell Line
Evgeny Levin, Premkumar Arumugam, Leo Veenman et al. · Biochemistry · 2005 · 74 citations
Peripheral-type benzodiazepine receptors: Their implication in brain disease
Leo Veenman, Moshe Gavish · Drug Development Research · 2000 · 68 citations
Medicine, Neuroscience, Pharmacology +12
Ligands of the mitochondrial 18 kDa translocator protein attenuate apoptosis of human glioblastoma cells exposed to erucylphosphohomocholine.
Wilfried Kugler, Leo Veenman, Yulia Shandalov et al. · PubMed · 2008 · 67 citations · Full text
1–5 of 29